NEWTON, Mass.--(BUSINESS WIRE)--May 8, 2006--Matritech (Amex: MZT - News), a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, announced today that the NMP22® BladderChek® Test will be featured in a podium presentation and a discussed poster presentation during the May 20-25, 2006 annual meeting of the American Urological Association (AUA) in Atlanta, Georgia. More than 10,000 urologists and healthcare professionals are expected to attend the conference.
